RSS

Alderley Park

An investment of £10 million will help develop high specification space for small bioscience businesses in the North of England. Read more

News

Contract research organisation Aptus Clinical has received £150,000 from the Northern Powerhouse Investment Fund (NPIF) – FW Capital Debt Finance, to help it expand. Read more

News

Independent provider of integrated drug discovery and pre-clinical services and expertise, Sygnature Discovery, has announced the next stage of its expansion plans with the addition of a new facility at Alderley Park. Read more

News

This year marks a decade for the OBN Awards, which celebrate and recognise those leading the way in the life sciences industry, and the list of finalists includes Alderley Park. Read more

News

A co-founder of the company ApconiX, based in Alderley Park, has revealed his view that attitude towards safety in pre-clinical cancer drug development needs to change. Read more

Opinion

The inaugural conference from Bionow, exploring the strengths in the discovery, development and manufacture of cancer medicines in the North of England, is to be hosted at Alderley Park later on this month (27 February). Read more

News

A nonclinical safety company that works with the pharma sector based in Alderley Park, ApconiX, has increased sales by five-fold as a result of the industry’s demand for drug safety expertise. Read more

News

A new research project between Medicines Discovery Catapult and the University of Leeds has started at Alderley Park, to bring microbubble technology a step closer to being used in patients. Read more

News

Alderley Park has been confirmed as the interim home for the Cancer Research UK (CRUK) Manchester Institute, underlining it as a key asset in the North of England. Read more

News

A nuclear magnetic resonance (NMR) facility has been launched at Manchester Science Partnership’s Alderley Park campus. Read more

News

Pharmaceutical company AstraZeneca has announced that it will be transferring certain UK based office jobs outside of the country to cut costs. Read more

News

The North of England is poised to lead research into tackling antimicrobial resistance (AMR), an issue deemed by the United Nations as “a fundamental threat to human health, development, security” according to Lord Jim O’Neill. Read more

News

BioNow and Manchester Science Partnerships (MSP) have launched a series of seminars, workshops and events aimed at addressing shortfalls in knowledge and best practice across life sciences. Read more

News

This is the first event in a new series of conferences for the life sciences and pharmaceutical sector which will take place at Alderley Park, Cheshire. Read more

News

A delegation from the North of England is heading to the BIO International Convention (BIO) in San Francisco this week – the first time the region’s life science sector has worked together to promote its offer on the global stage Read more

News

Alderley Park has launched its new Life Science Enterprise Zone in north England Read more

News

Redx Pharma is basing its new headquarters at Alderley Park, Cheshire, creating a drug development facility that brings together its three subsidiary businesses onto one site Read more

News

AstraZeneca to invest £75m in its packaging and manufacturing site in Macclesfield, Cheshire Read more

News